Form 4: Orgenesis Inc. Director Santhosh Nagaraj Acquires Stock Options

Director Santhosh Nagaraj of Orgenesis Inc. was granted stock options under the company's 2017 Equity Incentive Plan.

Summary

• Santhosh Nagaraj, a director at Orgenesis Inc., received stock options on December 12, 2024.
• The options were granted under the company's 2017 Equity Incentive Plan.
• A total of 1,875 options were granted, with an exercise price of $0.98 per share.
• 625 of the options vest in three years, one third each year starting December 12, 2025, December 12, 2026 and December 12, 2027.
• The remaining 1,250 options vest in one year, beginning on December 12, 2024.
• The vesting of all options is contingent on the director's continued service on the Board of Directors.

Sentiment

Score: 7

Explanation: The document reflects a standard practice of granting stock options to a director, which is generally viewed positively as it aligns interests. There are no negative implications.

Positives

• The granting of stock options aligns the director's interests with those of the shareholders.
• The vesting schedule encourages long-term commitment from the director.

Risks

• The value of the options is dependent on the future performance of Orgenesis Inc.'s stock price.
• If the director leaves the board before the vesting dates, the options may be forfeited.

Future Outlook

The director's future compensation is tied to the company's stock performance through these options.

Industry Context

Stock option grants are a common practice for incentivizing directors and aligning their interests with shareholders in the biotechnology industry.

Comparison to Industry Standards

• Stock option grants are a standard form of compensation for directors in publicly traded companies, particularly in the biotech sector.
• The vesting schedule of one to three years is also typical, designed to encourage long-term commitment and performance.
• Companies like Amgen, Gilead Sciences, and Regeneron Pharmaceuticals also use stock options as part of their director compensation packages.

Stakeholder Impact

• Shareholders may view this positively as it aligns the director's interests with the company's performance.
• The director is incentivized to contribute to the company's success to realize the value of the options.

Key Dates

Keywords

stock options, Orgenesis Inc., director, Santhosh Nagaraj, equity incentive plan, vesting